Quantinuum (QNT) SEC Filings

Quantinuum Inc. (QNT) reported third-quarter 2026 revenue of $9.1 million, up 233% from $2.7 million a year earlier, and raised its full-year 2026 revenue outlook to $31 million to $34 million from $28 million to $32 million. GAAP gross margin was 33.3%, compared with (43.5%) a year earlier; adjusted gross margin was 74.6%, up 853 basis points.

The quarter also produced a GAAP net loss of $118 million, compared with $52 million, and an adjusted EBITDA loss of $80 million, compared with $45 million. For the nine months ended September 30, revenue was $22.285 million, versus $23.908 million in 2025. Cash and cash equivalents were $1.94 billion as of September 30, 2026. Quantinuum signed its largest cloud agreement, a multi-year extension with a leading global financial institution that includes committed access through Apollo and Nexus. Nexus adoption reached 215 organizations, nearly 20% above the prior quarter, and Helios reached 99.9995% logical fidelity in October. Apollo remains on track for 2029.

BlackRock Portfolio Management LLC reported beneficial ownership of 1,664,459 shares of Quantinuum Inc. (QNT) Class A stock, equal to 4.5% of the class, as of September 30, 2026. It reported sole voting power over 1,521,301 shares and sole dispositive power over 1,664,459 shares; shared voting and dispositive power were both zero.

The reported holdings reflect certain business units of BlackRock, Inc. and its subsidiaries and affiliates, excluding securities attributed to other business units whose ownership is disaggregated.

Quantinuum Inc. is the subject of a joint ownership report covering its Class A common stock by six Citadel entities and Kenneth Griffin. Citadel Advisors LLC, Citadel Advisors Holdings LP and Citadel GP LLC each may be deemed to beneficially own 2,299,997 shares (7.0%). Citadel Securities LLC, Citadel Securities Group LP and Citadel Securities GP LLC each may be deemed to beneficially own 103,430 shares (0.3%). Kenneth Griffin, President and Chief Executive Officer of Citadel GP LLC, may be deemed to beneficially own 2,403,427 shares (7.3%). The reporting persons have shared voting and dispositive power, and zero sole voting and dispositive power. The reported percentages are based on 32,862,895 shares outstanding as of June 5, 2026.

Quantinuum Inc. (QNT) entered into a CHIPS Act Other Transaction Agreement with the U.S. Department of Commerce under which a subsidiary may receive up to $100.0 million in federal R&D funding for trapped‑ion quantum computing projects at U.S. sites. The award is structured as multiple payments, with $56.0 million available on or about September 4, 2026, and additional tranches of $32.0 million and $12.0 million tied to defined project milestones.

In connection with the award, Quantinuum issued 2,369,528 shares of Class A common stock to the Department of Commerce and granted registration rights, including a commitment to file and maintain a shelf registration statement covering resales. The award imposes extensive U.S. research‑security, domestic IP control, and domestic‑production requirements, with potential clawback of up to the full disbursed amount and termination rights for material non‑compliance, as well as long‑dated restrictions on transferring award‑funded intellectual property to foreign countries or entities of concern.

Honeywell International Inc., through itself and subsidiary Honeywell Holdings International Inc., reports beneficial ownership of Quantinuum Inc. Class A common stock as of June 30, 2026. Honeywell International beneficially owns 124,628,729 shares, representing 79.1% of Quantinuum’s Class A common stock, based on 32,862,895 shares outstanding at completion of Quantinuum’s June 5, 2026 initial public offering and assuming redemption of related LLC units into Class A shares.

The position includes 95,998,655 shares underlying units over which Honeywell International has sole voting and dispositive power and 28,630,074 shares over which voting and dispositive power is shared with Honeywell Holdings International. Honeywell Holdings International separately reports beneficial ownership of 28,630,074 shares, equal to 46.6% of the Class A common stock, all with shared voting and dispositive power.

Quantinuum Inc. (QNT) completed a transformative IPO on June 5, 2026, issuing 28,500,000 Class A shares at $60.00 per share and raising about $1.63 billion in net proceeds, which were used to purchase an equivalent number of Common Units in Quantinuum Holdings. This, along with related reorganization steps, created an Up‑C structure in which Quantinuum Inc. owns 13.7% of Quantinuum Holdings and Continuing Common Unitholders own 86.3%, reflected as a large non‑controlling interest.

For the six months ended June 30, 2026, revenue was $13.2 million, down from $21.2 million a year earlier, largely because 2025 included $16.5 million of sales‑type lease hardware revenue recognized at a point in time. Operating expenses rose sharply, driven by $447.5 million of stock‑based compensation recorded upon and after the IPO, pushing the net loss to $733.1 million, of which $65.4 million is attributable to Quantinuum Inc. Cash and cash equivalents increased to $2.11 billion, after $1.51 billion of net cash provided by financing activities, against $129.1 million used in operations and $39.2 million of capital expenditures. The company reports remaining performance obligations of $74.2 million and continues to invest heavily in R&D to develop its full‑stack quantum computing platform.

Capital Research Global Investors, a division of Capital Research and Management Company and its investment management affiliates, reported beneficial ownership of 1,754,325 shares of Quantinuum Inc. common stock. This represents 5.3% of the 32,862,895 shares believed to be outstanding.

Capital Research Global Investors reports sole voting and dispositive power over all 1,754,325 shares, with no shared voting or dispositive power.

Quantinuum Inc. reported strong top-line growth but deep losses for the quarter ended June 30, 2026. Revenue was $8 million, up 279% year-over-year from $2 million, driven by accelerating commercial activity. Despite this, profitability remains challenged: GAAP net loss was $597 million, compared with $57 million a year earlier, and Adjusted EBITDA loss was $68 million versus a $43 million loss in the prior-year quarter. GAAP gross margin improved to (64.4)%, a 27-point improvement, while Adjusted gross margin was 61.7%. The company completed a traditional IPO, raising $1.7 billion in gross proceeds, contributing to $2.1 billion in cash and short-term investments as of June 30, 2026, providing significant funding for its roadmap.

Management issued initial full-year 2026 guidance, expecting revenue of $28–$32 million, indicating continued growth from the current run-rate. Strategically, Quantinuum announced a multi-year partnership with Oracle to deploy its Helios trapped-ion quantum computer as a managed service on Oracle Cloud Infrastructure, supporting hybrid quantum-AI workloads and expanding enterprise and research access to its platform.

Quantinuum Inc. Chief HR Officer Rory Gordon O'Byrne filed an initial statement of beneficial ownership reporting 167,191 restricted stock units (RSUs) linked to Class A Common Stock. Each RSU represents a contingent right to receive one share, vesting under the applicable grant agreement, and no buy or sell transactions are reported.